What are the mechanisms of twin formation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mechanisms of Twin Formation

Twin formation occurs through two primary mechanisms: monozygotic twinning (identical twins) from a single fertilized egg that splits, and dizygotic twinning (fraternal twins) from two separate fertilized eggs. 1

Dizygotic (Fraternal) Twins

  • Result from the fertilization of 2 separate oocytes by 2 different sperm cells
  • Almost always have dichorionic-diamniotic placentation (two separate placentas and amniotic sacs)
  • Account for approximately two-thirds of all twin pregnancies 1
  • Influenced by maternal factors:
    • Family history of twinning, particularly on the maternal side 2, 3
    • Fertility treatments and assisted reproductive techniques 2

Monozygotic (Identical) Twins

Monozygotic twins result from a single fertilized egg (zygote) that splits into two genetically identical embryos. The timing of this split determines the placentation pattern:

  1. Early splitting (1-4 days after fertilization):

    • Results in dichorionic-diamniotic twins (separate placentas and amniotic sacs)
    • Occurs in approximately one-third of monozygotic twins 1
  2. Intermediate splitting (4-8 days after fertilization):

    • Results in monochorionic-diamniotic twins (shared placenta, separate amniotic sacs)
    • Most common type, occurring in about two-thirds of monozygotic twins 1
    • These twins share a single placenta with intertwin vascular anastomoses connecting their circulations 1, 4
  3. Late splitting (8-12 days after fertilization):

    • Results in monochorionic-monoamniotic twins (shared placenta and amniotic sac)
    • Occurs in less than 1% of monozygotic twins 1
    • Higher risk due to potential cord entanglement 1
  4. Very late splitting (>12 days after fertilization):

    • Results in conjoined twins (incomplete separation)
    • Extremely rare 1

Cellular Mechanisms

Recent research suggests that monozygotic twinning may involve specific cellular mechanisms:

  • For monochorionic twins, a looser inner cell mass (ICM) in blastocysts increases the chance of ICM separation
  • Physical forces from blastocoel formation or "8-shaped hatching" can exert pressure on the ICM, resulting in splitting 5
  • The architecture of the zona pellucida (the protective layer around the embryo) may influence monozygotic twinning, particularly in IVF cases 6

Clinical Implications of Chorionicity

Understanding chorionicity is critical as it determines risk profiles:

  • Monochorionic twins share a placenta with vascular anastomoses in over 95% of cases 1
  • Monochorionic twins have more than twice the perinatal mortality rate compared to dichorionic twins (7.6% vs 1.6% fetal demise) 1
  • Monochorionic placentation can lead to unique complications such as:
    • Twin-twin transfusion syndrome (TTTS)
    • Twin anemia-polycythemia sequence (TAPS)
    • Selective fetal growth restriction 1, 4

Unusual Findings

  • Rare cases of monochorionic-dizygotic twins have been reported, challenging the traditional understanding that monochorionicity always indicates monozygosity 1
  • Some research suggests that monozygotic and dizygotic twinning might share more embryogenic mechanisms than previously thought 7

Accurate determination of chorionicity by ultrasound is most reliable between 10-14 weeks of gestation, with the presence of a "lambda" or "twin peak" sign indicating dichorionic placentation 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Familial twinning and fertility in Dutch mothers of twins.

American journal of medical genetics. Part A, 2008

Guideline

Twin-Twin Transfusion Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.